Azenta, Inc. (NASDAQ:AZTA – Get Rating)’s share price reached a new 52-week low on Friday after B. Riley lowered their price target on the stock from $94.00 to $82.00. The company traded as low as $60.81 and last traded at $61.77, with a volume of 2873623 shares trading hands. The stock had previously closed at $74.16.
Other equities analysts have also issued research reports about the company. Needham & Company LLC dropped their price objective on Azenta from $115.00 to $94.00 in a report on Tuesday, May 10th. Evercore ISI started coverage on Azenta in a report on Monday, March 21st. They set an “outperform” rating and a $100.00 price objective on the stock.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in AZTA. Amalgamated Bank purchased a new position in shares of Azenta during the first quarter worth about $4,552,000. West Coast Financial LLC purchased a new position in shares of Azenta during the second quarter worth about $3,162,000. Brasada Capital Management LP purchased a new position in shares of Azenta during the first quarter worth about $2,937,000. IMA Wealth Inc. purchased a new position in shares of Azenta during the first quarter worth about $1,818,000. Finally, Green Alpha Advisors LLC purchased a new position in shares of Azenta during the second quarter worth about $864,000. 94.02% of the stock is currently owned by hedge funds and other institutional investors.
The stock has a fifty day simple moving average of $72.49 and a two-hundred day simple moving average of $80.43. The company has a market cap of $4.63 billion, a PE ratio of 2.09 and a beta of 1.60.
Azenta (NASDAQ:AZTA – Get Rating) last announced its quarterly earnings data on Monday, May 9th. The company reported $0.12 earnings per share for the quarter, beating analysts’ consensus estimates of $0.11 by $0.01. Azenta had a return on equity of 4.28% and a net margin of 301.05%. The company had revenue of $145.60 million for the quarter, compared to analyst estimates of $142.10 million. During the same quarter in the previous year, the company earned $0.61 EPS. The firm’s revenue for the quarter was up 12.3% compared to the same quarter last year. On average, equities analysts expect that Azenta, Inc. will post 0.51 EPS for the current fiscal year.
Azenta Company Profile (NASDAQ:AZTA)
Azenta, Inc provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows.